By Dani Kass ( June 6, 2016, 4:25 PM EDT) -- The U.S Supreme Court on Monday declined to hear GlaxoSmithKline LLC's appeal of a Third Circuit decision that a class may sue them under the Racketeer Influenced and Corrupt Organizations Act, in a case alleging the British drugmaker hid risks about its diabetes drug Avandia to inflate profits....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.